reSee.it - Related Video Feed

Ivermectin, a 62-year-old drug, has received a Nobel Prize for its unique properties. It has been found to block 8 pathways to cancer, making it a valuable repurposed drug in cancer treatment.

Ivermectin is claimed to be a "miraculous drug" that works for COVID-19 and influenza, potentially including H5N1. It has reportedly cleared psoriasis and Lyme disease in some patients. Repurposed drugs like ivermectin, initially designed for one purpose, are now being used for other conditions, including stage four cancer. Topical ivermectin cream is FDA-approved for rosacea, but horse paste is stronger and can treat inflammatory or autoimmune skin conditions, cystic acne, eczema, and skin cancers. Testimonials suggest that applying horse paste twice daily can cause lesions from basal cell carcinoma, squamous cell carcinoma, and melanoma to shrink and disappear within a couple of months. One patient reported that ivermectin applied to a tongue cancer caused the lesion to shrink. Women have also reported that it shrinks breast lumps and cysts. Oral ivermectin may help with autoimmune conditions like rheumatoid arthritis and juvenile rheumatoid arthritis. Low doses of 12-24mg may be effective for inflammatory conditions.

Ivermectin is a versatile drug with antiviral and anti-inflammatory properties that stimulate healing processes like autophagy and improve the microbiome. It is effective for early COVID treatment and vaccine injuries, and is affordable as a generic drug. Despite misconceptions, it is not a horse dewormer and has been available for as little as 2¢ per tablet through the WHO.

There is a drug called Ivermectin that has proven to be highly effective in combating the current crisis. This is not an exaggeration, but a scientific recommendation based on extensive data gathered over the past three months. The NIH's recommendation against using Ivermectin outside of controlled trials was made in August, but since then, numerous studies from various countries have shown its miraculous impact. It has been found to completely prevent the transmission of the virus and ensure that individuals who take it do not get sick.

I found over 100 scientific papers showing Ivermectin's potential against cancer, primarily from preclinical studies. Researchers are puzzled by how this anti-parasitic drug, which has been effective for decades, can also treat cancer. Ivermectin is off patent, meaning there's little financial incentive for big pharma to invest in its research. Notably, Ivermectin can kill cancer stem cells, reverse chemotherapy resistance, and enhance the effectiveness of both chemotherapy and radiation. Patients combining Ivermectin with these treatments have shown remarkable results, including significant tumor reductions. After two years of research, I now treat over 1,000 cancer patients with Ivermectin and other anti-parasitic drugs. The recent mention by Mel Gibson about friends curing stage 4 cancer with these treatments highlights the growing awareness of this approach.

Doctors in Australia have found a potential cure for the coronavirus using a drug called Ivermectin. Although it is typically used for parasitic infections, a study from Monash University showed that even a single dose of Ivermectin could kill the virus in less than 48 hours. The drug is FDA approved, on the World Health Organization's list of essential medicines, and has minimal side effects. It is also inexpensive, costing just 12¢ for a course of treatment. Australian doctor Thomas Borody recommends using Ivermectin in combination with two other drugs, doxycycline and zinc, for maximum effectiveness. Doctors in Broward County, Florida have also reported success in treating coronavirus patients with Ivermectin.

Ivermectin, known for its use in treating COVID-19, has also shown promise in treating aggressive cancers such as glioblastomas, stage 4 breast and colon cancers, pancreatic cancers, gallbladder cancers, renal cancers, and melanomas. Research suggests that higher doses of Ivermectin can halt the growth and metastasis of these cancer cells, as well as induce apoptosis and autophagy to kill them. It is worth considering Ivermectin as a potential treatment for these aggressive cancers, in addition to its effectiveness against viral outbreaks.

In 2002-2003, North American science conducted experiments and research on the original SARS CoV-one. By 2015-2016, it was known that Ivermectin and hydroxychloroquine were effective against viruses and could modulate the immune response. DARPA, the American Research Arm of the U.S. Military, recommended Ivermectin to the CDC as the top product for a coronavirus pandemic. These medications have been used safely in humans for 35 to 40 years. So, when the next pandemic hit, Ivermectin was ready to be used.

Ivermectin, a 62-year-old drug, has been found to have multiple uses. It received a Nobel Prize for its unique abilities, including blocking 8 pathways to cancer. As a result, Ivermectin is now being repurposed as a treatment for cancer patients.

Doctors in Australia have found a potential cure for the coronavirus using a drug called Ivermectin. This medicine, which is already FDA approved and on the World Health Organization's list of essential medicines, has been shown to kill the virus in less than 48 hours. It is safe, widely available, and inexpensive, costing just 12 cents for a course of treatment. When combined with two other drugs, doxycycline and zinc, Ivermectin has been found to be highly effective in treating the virus. Doctors in Broward County, Florida have reported a near 100% success rate in curing coronavirus patients using Ivermectin. However, it remains to be seen how other medical experts will respond to this discovery.

Ivermectin has shown effectiveness in preventing COVID-19 infection, as evidenced by a trial in Argentina where 800 healthcare workers were prophylaxed and none got sick, compared to 58% of those who were not given Ivermectin. It has also demonstrated antiviral activity and has been proven effective as a prophylaxis agent in four large randomized controlled trials. In early outpatient treatment, it reduces the need for hospitalization and death, as shown in three randomized controlled trials and multiple case series. In hospitalized patients, Ivermectin has consistently shown lower mortality rates in four randomized controlled trials. It has already won the Nobel Prize in Medicine in 2015 for its impact on global health.

Ivermectin, a 62-year-old drug, has been recognized with a Nobel Prize for its unique properties. It effectively blocks 8 pathways to cancer, making it a valuable repurposed drug for cancer patients.

We discovered that Ivermectin can kill COVID-19 in primate cells. A single dose of the drug stopped the virus from replicating within 48 hours. Human trials are on the horizon, as the drug has been safely used for decades. Repurposing existing drugs like Ivermectin can speed up development by utilizing known safety profiles and administration methods. We are working on determining if these benefits can translate to treating COVID-19 in humans.

Ivermectin, known for its use in treating COVID-19, has also shown promise in treating aggressive cancers like glioblastomas, stage 4 breast and colon cancers, pancreatic cancers, gallbladder cancers, renal cancers, and melanomas. Research suggests that higher doses of Ivermectin can halt the growth and metastasis of these cancer cells, inducing apoptosis and autophagy to kill them. It is worth considering Ivermectin as a potential treatment for these turbo cancers, in addition to its effectiveness against viral outbreaks.

The North American scientific community spent 15 years planning for the next Covid epidemic. In 2000-2003, SARS-CoV-1 emerged, leading to various experiments to determine the best response for a similar event. By 2015-2016, research was completed, and the US military's research branch, DARPA, specifically recommended and informed the CDC that ivermectin was the top product to use in a coronavirus pandemic. It was known that ivermectin and hydroxychloroquine were highly antiviral and immunomodulatory. These elements were proven effective in stimulating the immune response and fighting viruses in both lab and animal studies. These drugs have been used safely in humans for 35-40 years, making them ready for the next pandemic.

Ivermectin is safer than a sugar pill, with minimal toxicity. It has been falsely labeled as a horse dewormer by the FDA, despite its extensive safe use in humans. Over 3.7 billion doses have been given, showing its safety. While its efficacy is debated, it is a low-risk, cost-effective option for treating sick patients.

Ivermectin, a 62-year-old drug, has been found to have multiple uses. It received a Nobel Prize for its unique abilities, including blocking eight pathways to cancer. As a result, Ivermectin is now being repurposed as a treatment for cancer patients.

In 1970, a Japanese biochemist named Satoshi Omorra discovered a bacterium with intriguing effects against roundworm and shared it with American colleague William Campbell of Merck. Campbell used the bacterium to create ivermectin, released by Merck in 1980. Ivermectin proved extremely effective against river blindness (onchocerciasis), a disease caused by a parasitic worm that affected Central and South America and much of Africa. With ivermectin, river blindness has been largely eliminated in the Americas and greatly reduced in Africa. Billions of doses have been administered; it is listed among the World Health Organization’s essential medicines. Merck’s patent expired in 1996; the drug is cheap to produce, globally available in various formulations, and, at normal dosages, has no important side effects. In 2015, Omurra received the Nobel Prize for Medicine, shared with Campbell. Fast forward to early 2020, when the COVID-19 pandemic spread. Scientists searched for drugs with antiviral activity, and Monash University in Australia conducted a literature search that found ivermectin had shown activity against Zika, West Nile, and influenza. They performed experiments and found that ivermectin displays remarkable activity against SARS-CoV-2 in vitro, reporting a 5,000-fold reduction in viral levels after a single treatment without cytotoxicity, and proposed a mechanism for this effect. Around the same time, two American scientists noted that ivermectin was used as prophylaxis against river blindness in Africa and examined whether widespread ivermectin prophylaxis correlated with COVID-19 rates. They found that countries with extensive ivermectin prophylaxis had significantly lower COVID-19 rates. In Miami, Dr. Jean Jacques Reiter, a critical care and pulmonary specialist, treated COVID-19 patients with ivermectin after being urged by a patient’s son. He reported rapid improvement: the patient’s FiO2 requirements declined within 48 hours, and she was discharged within about a week. Reiter treated many patients with ivermectin and published a June 2020 preprint; he later testified before a Senate committee about his experiences. He stated that among hundreds of outpatients treated by his team, only two were admitted to the hospital; neither died or required intubation. Uncontrolled studies on ivermectin as prophylaxis and treatment circulated globally. A daughter described a care-home incident in Ontario, where residents on a floor receiving high-dose ivermectin for scabies reportedly had no COVID-19 infections among residents, even as staff on that floor became infected. In New York, Pierre Corry teamed with Reiter and Paul Merrick to form the Frontline COVID-19 Critical Care Alliance (FLCCC). In October 2020, the FLCCC released the Eye Mask Plus protocol, centering on ivermectin for prevention and treatment, and published a meta-analysis reviewing nine studies on prophylaxis and 12 studies on treatment, including seven randomized trials, all showing ivermectin’s superiority to controls. They presented figures showing reduced mortality and case rates associated with ivermectin use in various regions, including Peru, Mexico (Chiapas), and Argentina (healthcare workers). On December 8, 2020, FLCCC members appeared before a Senate subcommittee, with testimony claiming mountains of data showing ivermectin’s miraculous effectiveness and requesting the NIH to review their data. The transcript asserts widespread suppression of ivermectin information by mainstream media (New York Times, AP), big tech (YouTube, Twitter, Facebook), and the NIH. It alleges the NIH COVID-19 treatment guidelines panel, established in April 2020, largely recommended against early treatment and promoted remdesivir instead, even though remdesivir’s mortality impact was unproven and the World Health Organization advised against its use for improving survival. The panel’s treatment recommendations (as of 01/03/2021) are cited, highlighting monoclonal antibodies for early patients and no other treatments, except for remdesivir for deteriorating patients. Fauci publicly touted remdesivir’s endpoint as time to recovery, with the primary endpoint reportedly changed mid-trial from mortality to time to recovery, raising concerns about impartiality. The transcript traces remdesivir's production by Gilead Sciences and notes financial ties: seven panel members disclosed funding from Gilead; two of the three panel chairs received Gilead support, and Clifford Lane (one co-author on a remdesivir study) was closely connected to the study, with undisclosed ties among other authors. It argues these ties could impact decision-making and bias toward remdesivir over cheaper, repurposed drugs like ivermectin. The narrative then contrasts the U.S. approach with Uttar Pradesh, India, which authorized ivermectin as prophylaxis and treatment in August 2020. In January 2021, Uttar Pradesh reported near-zero COVID-19 deaths, while the United States faced ongoing high mortality, suggesting potential differential outcomes if ivermectin had been broadly authorized. The closing remarks emphasize the suffering caused by COVID-19 and its broad impacts on families and society.

Ivermectin, once considered a conspiracy theory, is now reportedly curing diseases like cancer, diabetes, MS, and Parkinson's by addressing parasites. The speaker prefers the dura mectin version, a white paste, over the ivermectin yellow gel. According to the speaker, no one has ever died from ivermectin overdose, unlike aspirin and acetaminophen. Ivermectin won a Nobel Prize in 2015 for its effectiveness against diseases like malaria. Positive effects were seen for COVID, but its use was discouraged to maintain the emergency declaration. The speaker takes a full capsule of ivermectin daily for two weeks, followed by a week off, as a prophylactic. They wash it down with a sweat tonic containing quinine, which is hydrochloroquine. Hydrochloroquine and ivermectin were allegedly dismissed by organizations like the WHO, despite being effective. Links to more information are provided in the comments.

North American science spent 15 years researching how to respond to a future coronavirus pandemic after the original SARS CoV-one outbreak in 2002-2003. By 2015-2016, research showed that Ivermectin and Hydroxychloroquine were effective antiviral and immune modulatory treatments. The US military's research arm, DARPA, recommended Ivermectin as the top choice for a coronavirus pandemic and shared this information with the CDC. These medications had been proven safe for humans and had been used for several decades. They were ready to be used in the event of a future pandemic.

North American science spent 15 years preparing for the next COVID after the original SARS CoV 1 outbreak in 2002-2003. By 2015-2016, research was complete. DARPA recommended to the CDC that ivermectin was the number one product to use in the event of a coronavirus pandemic. Ivermectin and hydroxychloroquine were known to be highly antiviral and immune modulatory. These effects were proven in vitro and in vivo with animals. Both medications were known to be completely safe for humans, having been used for 35 to 40 years. This knowledge was readily available for use at the next pandemic.

There is a growing problem of people using a drug meant for animals to treat COVID-19. This false information started with a viral video from a group called America's frontline doctors, claiming that hydroxychloroquine could cure COVID. They later started promoting another drug called Ivermectin as a cure for COVID, despite warnings from the CDC, FDA, and other health organizations that it is not effective and could be harmful. Ivermectin is actually meant to prevent parasites in animals like horses. It's important to rely on approved treatments and vaccines to prevent COVID-19.

Ivermectin, discovered by scientists Satoshi Omura and William C. Campbell, is a drug that kills parasites by disabling their neurons. It was originally used to treat river blindness in Africa, a disease that caused many people to lose their eyesight. Thanks to Ivermectin, this disease is now close to being eliminated. The drug has had a significant impact on human health and is considered second only to penicillin. Over the past 30 years, humans have taken approximately 3.7 billion doses of Ivermectin.

Ivermectin, a Nobel Prize-winning anti-parasitic drug, has been vilified. Merck, who held the patent until 1996, claims it doesn't work for COVID-19. However, Merck has a 50/50 partnership with Moderna on mRNA cancer vaccines. Because Merck will make billions on mRNA cancer vaccines, they have no interest in investigating ivermectin for cancer. There is evidence that high-dose ivermectin is effective in treating many types of cancers.

A study on Ivermectin's effectiveness in reducing COVID-19 deaths has been peer-reviewed and published. The study analyzed excess deaths in Peru in 2020 and found that states with intensive Ivermectin use had a 74% reduction in excess deaths. When Ivermectin use was restricted, there was a 13-fold increase in deaths. The study concluded that Ivermectin showed strong evidence of effectiveness, considering potential confounding factors. The study was published on August 8th, 2022.